Inmune Bio Inc. (INMB)
NASDAQ · Healthcare
Inmune Bio Inc. Shareholder Equity 2017–2025
Inmune Bio Inc. annual shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Inmune Bio Inc. shareholder equity as of December 31, 2025: 23.5M, a 26.71% decrease year-over-year.
- Inmune Bio Inc. shareholder equity for 2025 were 23.5M, a 26.71% decrease from 2024.
- Inmune Bio Inc. shareholder equity for 2024 were 32.1M, a 14.04% decrease from 2023.
- Inmune Bio Inc. shareholder equity for 2023 were 37.3M, a 37.87% decrease from 2022.
- Inmune Bio Inc. shareholder equity for 2022 were 60.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Inmune Bio Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $24 |
| 2024 | $32 |
| 2023 | $37 |
| 2022 | $60 |
| 2021 | $80 |
| 2020 | $39 |
| 2018 | $17 |
| 2017 | $18 |
Inmune Bio Inc. Shareholder Equity — FAQ
Inmune Bio Inc. (INMB) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INMB's shareholder equity history?
The chart and table above show Inmune Bio Inc.'s shareholder equity by year and by quarter, including the growth rate.